Regenicin, Inc.RGINBalance sheet

Market cap
$15.35K
P/E ratio
2011/092012/092013/092014/092015/092016/092017/092018/092019/092020/092021/09
Cash and cash equivalents ---4921218,84719,2012,7028151,366-
Total cash & short-term investments---4921218,84719,2012,7028151,366-
Total current assets78,02688,41388,83531292,56587,793----
Total non-current assets337,5007,500-67,268-----
Total assets 3396,33531359,83387,79356,4335,3154,1414,609
Accounts payable739,327211360,228262,934280,96167,532138,29888,65993,674
Total current liabilities14442233445
Total non-current liabilities--438,779--------
Total liabilities 1444-------
Common stock and paid-in capital 779910101010101010
Retained earnings-4,660,332-8,187,901-13,092,713-10,952,591-10,709,992-11,799,894-12,773,831-13,332,889-14,090,395-14,649,98616
Stockholders' equity2-454,482-4,139,738-1,516,694-768,043-1,468,008-2,441,445-3,000,053-3,727,685-4,287,276-5,164,378